Connect with us

Spread & Containment

Tech Giants Could Send Helium Prices Soaring as War For Supply Grows

It’s a global issue that could soon disrupt every industry from technology to medicine and much more.
With the global supply of one commodity at its lowest level in years… while demand is spiking to all-time highs…
It could send prices for this…

Published

on

It's a global issue that could soon disrupt every industry from technology to medicine and much more.

With the global supply of one commodity at its lowest level in years... while demand is spiking to all-time highs...

It could send prices for this much-needed resource higher yet.

Already, prices had been steadily climbing in recent years.


Source: Bureau of Land Management, USGS

But one small company, Avanti Energy (TSX: AVN.V; US OTC: ARGYF), has seen its share price increase more than 2.5x over just the last few months.

Those recent gains are greater than many of those companies filling the headlines today.

Now, an event set to take place in September 2021 has the potential to send helium prices to the next level.

That's when the global supply of this rare gas could nosedive by as much as 10%.

And that's why some of the biggest media outlets in the world are finally starting to take notice.

Forbes is saying, "Helium is soaring on red-hot demand, shrinking supply."

CNBC points out, "The worldwide helium shortage affects everything from MRIs to rockets."

And the Wall Street Journal is saying, "The gas is crucial in high-tech and medical device manufacturing [...] operations."

With top media outlets now turning their attention to this supply squeeze, it’s clear that the world is facing a potential shortage.

You see, helium is about far more than party balloons.

Big Tech companies like Amazon, Alphabet, Facebook, and many others all rely heavily on this valuable gas.

Because it has the lowest boiling point of any element, it can bring temperatures to lower levels than even liquid nitrogen.

That's incredibly important when you're keeping electronics from overheating.

1) This is crucial for Big Tech’s data centers, as they run around the clock, crunching more data than ever.

2) It's essential for creating computer chips we rely on in every computer and smartphone we own.

3) And the health sector requires them to cool the magnets inside MRI machines.

Helium even plays a critical role in space exploration, quantum computing, and nuclear power.

In today's high-tech era, it's needed nearly everywhere you look.

That's why it's such a concern that supply levels are reducing to the lowest level we've seen in years.

Those in the medical field even went as far as to ask balloon retailers to give up 10% of the helium supply recently to help address the shortage.

If helium levels run out altogether, the effects could be very expensive.

Imagine the impact on fiber optic cables for high speed internet. On cell phones or computers. On MRIs. And even on airbags for our cars.

That’s why this precious gas is now much more valuable than natural gas, at prices of $14.6/Mcf versus just $2.80/Mcf.

And that's great news for little-known helium exploration companies like Avanti (TSX: AVN.V; US OTC: ARGYF).

The junior mining company has already seen shares soar over 2.5x in just three months.


Source: Beacon Securities Limited

But with the looming deadline of the September 2021 event, Avanti Energy (TSX: AVN.V; US OTC: ARGYF) seems to be on the right track.

World-Class Team Jumping On A Massive Opportunity

Avanti recently acquired the license for 6,000+ acres of land in Alberta, Canada that the experienced team says is highly prospective for helium.


Source: Beacon Securities Limited

Around the world, most of the largest supplies of helium have had one thing in common.

They were discovered in areas where there's been drilling for natural gas.

That’s a major reason why Avanti has targeted the site where the government of Alberta previously explored for oil and gas wells.

So we think it already fits the criteria from that angle.

But it's also positioned in an area where there's been multiple drill system tests with analyzed natural gas.

And it's got the potential to be high-grade gas as well.

When it comes to commercially viable grades of helium, experts consider anything from 0.3% to 1% helium to be high-grade.

But on the Alberta property, historical drilling is reported to have showed up to 2.18% helium in some locations.

We think this could have tremendous implications for supply if the hoped for discovery in Alberta pans out as Avanti’s team is expecting.

For prospective helium plays like these though, even when there's great potential, many fall apart just due to poor leadership or lack of experience, in addition to other reasons.

That's why it's essential to only back projects led by teams that have already proven they can deliver the goods.

And that's exactly what we think Avanti Energy (TSX: AVN.V; US OTC: ARGYF) has on their side.

Team of Experts with a Proven Track Record

Their world-class management team was responsible for identifying and developing one of the largest oil and gas discoveries in all of North America.

That's where they helped discover natural gas in the Montney, which has been producing almost 300,000 boe/d over the past 15 years.

And now, Genga Nadaraju, Dr. Jim Wood, and Ali Esmail have keyed in on the Alberta property because of the incredible potential they've seen there.

They've probably already developed a plan for identifying the structural traps and high points for drilling.

But many are eagerly waiting to see how these world-class experts will do it.

They've already revealed that they're pursuing an 80-20% targeted model approach.

The 20% will follow standard industry conventional strategies.

But the remaining 80%, which could be the key to helping unlock the opportunities at the Alberta property, is being kept strictly confidential.

It’s expected that they’ll plan to follow their own models, just as they did at the Montney.

And they’re hoping they’ll see similar results with another world-class discovery in their new property, this time of a different kind of gas.

Expanding Quickly Throughout North America

With such a highly-respected team behind this project, it's beginning to draw attention within the industry.

That's especially true after Avanti moved to grow their land package across the border into the United States earlier in April.

They’ve entered into an LOI to add another 12,000 acres of land in Montana to this already impressive land package in Alberta.

And they're supposedly eyeing another roughly 55,000 acres around the midwestern United States with potentially very large helium reserves.

Altogether, they're said to have identified around 20 additional proprietary targets around Alberta, Saskatchewan, and Montana.

And over the coming months, they've made clear that they are planning to aggressively start acquiring more land to build a long-term pipeline of opportunities and projects.

That's massive news as the supply squeeze for helium has a lot of different industries seeking what Avanti is looking to be able to supply.

And once the Helium Stewardship Act expires in September 2021, that's only expected by some experts to push helium prices higher.

That's when the United States Bureau of Land Management (BLM) will auction off all remaining helium reserves in their possession, which could do away with the price ceiling keeping the lid on the market today.

Avanti Energy (TSX: AVN.V; US OTC: ARGYF) is in a good position to cash in if they achieve the discoveries they’re aiming for as they assemble a growing property portfolio that's highly prospective for helium.

Now, with the success of this tech boom riding on companies like Avanti discovering and producing more helium in the coming months, the potential upside looks good to us.

So how does Big Tech use helium, anyway?

It’s used primarily for cooling in fiber optic manufacturing and semiconductor manufacturing. That means that companies with massive data centers like Google, Facebook and Microsoft are distinctly dependent on this rare gas.

Other energy plays to keep an eye on:

As demand for energy continues to explode in a post-pandemic China, CNOOC Limited (NYSE:CEO, TSX:CNU) will likely be one of the biggest winners in this boom. It’s the country’s most significant producer of offshore crude oil and natural gas and may well be one of the most controversial oil stocks for investors on the market. A label that has nothing to do with its operations, however.

Just last month, U.S. regulators announced their intention to de-list Chinese companies from the New York Stock Exchange, going back on their announcement just a few days later. The sustained negative press surrounding Chinese companies, however, has put CNOOC in an uncomfortable position for investors. While many analysts see the company as significantly undervalued, it is still struggling to gain traction in U.S. markets.

Teck Resources Limited (NYSE:TECK, TSX:TECK.B) is one of the world’s largest and most diverse resource and mineral companies. And it isn’t going to miss out on the global energy transition, either. While its primary mining and mineral development plays focus on steelmaking coal, copper and zinc, Teck also has a major stake in renewable projects with massive potential.

Explaining why investment in the new-energy industry, Teck states, “Flow batteries – such as the zinc-air battery developed by ZincNyx, with its flexible and low-cost scaling, long-term storage properties and the ability to separate the energy storage function from the power generation source – could provide a more efficient alternative for large-scale energy storage.” 

Like the rest of the market, Teck struggled in 2020. Its share price fell to just $7 in March of last year due to the market chaos sparked by the COVID-19 pandemic. Despite this downturn, however, the company was able to rebound significantly, rising by nearly 180% to its current prices. But with more projects on the horizon, and global demand for copper and zinc on the rise, Teck is poised to climb even higher.

Turquoise Hill Resources Ltd. (NYSE:TRQ, TSX:TRQ) is major player in Canada’s resource and mineral industry, and its bound to gain some major traction in the world’s push towards greener energy. Like Teck Resources, Turquoise Hill is a major producer of coal and zinc, two resources with distinctly different futures. While the end of coal is looming, zinc is a mineral that will likely grow exponentially in the future of energy for years and years to come.

But that’s not all Turqoise Hill has going for it in the energy transition. It’s also a major producer of Uranium. Uranium is a key material in the production of nuclear energy, which many analysts are suggesting could be a major component in the global transition to cleaner energy. While the mineral has not seen significant price action in recent years, there are a number of new projects set to come online across the globe in the medium-term, which could be a boon to Turquoise Hill.

Magna International (NYSE:MGA, TSX:MG) is a little-known stock with huge potential. And it is a great way to get in on the booming battery market without betting big on one of the new hot stocks tearing up among the millennials right now. The 63-year-old Canadian manufacturing giant provides mobility technology for automakers of all types. From GM and Ford to luxury brands like BMW and Tesla, Magna is a master at striking deals. And it’s clear to see why. The company has the experience and reputation that automakers are looking for.

Magna saw the battery boom before most. In fact, more than ten years ago, it was already making major moves in this emerging market, investing over half a billion dollars in battery production while the market was still gaining traction. Back then, electric vehicles as we know them had barely hit the scene, with Tesla launching its very first car just two years before.

Magna’s big bet on batteries has paid off in a big way. Since its initial investment the company has seen its valuation soar by tens of billions of dollars, and it has quietly solidified itself as one of the leaders in this emerging market. 

Similar to Magna, Celestica (NYSE:CLS, TSX:CLS ), is a company that saw this trend before it took Wall Street by storm. As a manufacturer of key technology in this industry, it has gained a lot of ground, especially in recent years. Celestica’s wide range of products includes but is not limited to communications solutions, enterprise and cloud services, aerospace and defense products, renewable energy and healthcare tech.

Celestica’s future is tied hand-in-hand with the green energy boom that’s sweeping the world at the moment. It helps build smart and efficient products that integrate the latest in power generation, conversion and management technology to deliver smarter, more efficient grid and off-grid applications for the world’s leading energy equipment manufacturers and developers.

Celestica fell victim to the massive selloff sparked by the global COVID-19 pandemic, seeing its share price fall into the $2 range in March 2020. Since then, however, the stock price has soared by nearly 400% to its current price. This could be just the beginning for Celestica, however. As the pressure continues to grow to go green, Celestica may emerge as a major benefactor in this new energy race.  

By. Arakan Okada

**IMPORTANT! BY READING OUR CONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING. PLEASE READ CAREFULLY**

Forward-Looking Statements

This publication contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this publication include that prices for helium will significantly increase due to global demand and use in a wide array of industries and that helium will retain its value in future due to the demand increases and overall shortage of supply; that Avanti can pursue exploration of the recently acquired licenses of property in Alberta; that Avanti’s licenses in respect of the Alberta property can achieve drilling and mining success for helium; that Avanti will be able acquire the rights to helium on 12,000 acres of prospective land in Montana pursuant to its recently announced letter of intent; that the Avanti team will be able to develop and implement helium exploration models, including their own proprietary models, that may result in successful exploration and development efforts; that historical geological information and estimations will prove to be accurate or at least very indicative of helium; that high helium content targets exist in the Alberta and Montana projects; and that Avanti will be able to carry out its business plans, including timing for drilling and exploration. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Risks that could change or prevent these statements from coming to fruition include that demand for helium is not as great as expected; that alternative commodities or compounds are used in applications which currently use helium, thus reducing the need for helium in the future; that the Company may not fulfill the requirements under its Alberta licenses for various reasons or otherwise cannot pursue exploration on the project as planned or at all; that the Company may not be able to acquire the helium rights to the Montana lands as contemplated in the letter of intent or at all; that the Avanti team may be unable to develop any helium exploration models, including proprietary models, which allow successful exploration efforts on any of the Company’s current or future projects; that Avanti may not be able to finance its intended drilling programs to explore for helium or may otherwise not raise sufficient funds to carry out its business plans; that geological interpretations and technological results based on current data may change with more detailed information, analysis or testing; and that despite promise, there may be no commercially viable helium or other resources on any of Avanti’s properties. The forward-looking information contained herein is given as of the date hereof and we assume no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

DISCLAIMERS

This communication is for entertainment purposes only. Never invest purely based on our communication. Oilprice.com and its owners and affiliates (“Oilprice.com”) have not been compensated by Avanti but may in the future be compensated to conduct investor awareness advertising and marketing for TSXV:AVN. The information in this report and on our website has not been independently verified and is not guaranteed to be correct.

SHARE OWNERSHIP. The owner of Oilprice.com owns shares of Avanti and therefore has an additional incentive to see the featured company’s stock perform well. Oilprice is therefore conflicted and is not purporting to present an independent report. The owner of Oilprice.com will not notify the market when it decides to buy more or sell shares of this issuer in the market. The owner of Oilprice.com will be buying and selling shares of this issuer for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. 

NOT AN INVESTMENT ADVISOR. Oilprice.com is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation, nor are any of its writers or owners.

ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

RISK OF INVESTING. Investing is inherently risky. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any stock acquisition will or is likely to achieve profits.

Read More

Continue Reading

Spread & Containment

China Suspends Travel, Ramps Up Testing As Delta Outbreak Hits Wuhan

China Suspends Travel, Ramps Up Testing As Delta Outbreak Hits Wuhan

China’s worst outbreak since COVID first emerged in the city of Wuhan has continued to spread, prompting authorities to intensify their efforts to crush the delta-driven…

Published

on

China Suspends Travel, Ramps Up Testing As Delta Outbreak Hits Wuhan

China's worst outbreak since COVID first emerged in the city of Wuhan has continued to spread, prompting authorities to intensify their efforts to crush the delta-driven outbreak. However, as the virus continues to elude their grasp, it's looking increasingly likely that Beijing's "zero tolerance" approach might hamstring economic growth, as analysts from Goldman Sachs warned in a recent note to clients.

More than 2 dozen cities have counted more than 300 cases over the past few weeks as the number of cases has quickly multiplied. China now has 144 medium- and high-risk areas - the most since the initial outbreak in early 2020, according to the National Health Commission.

By Monday, all of China's 31 provincial-level jurisdictions had issued notices by Monday advising people not to travel domestically. Some provincial governments singled out only medium- and high-risk regions, while others asked people to avoid all inter-provincial travel. According to the SCMP, Beijing's "zero-tolerance" approach to fighting COVID, which remains minimal compared with China's vast population, has "scared away" the tourists.

China reported 71 new COVID cases from local transmission on Wednesday, more than half of them in coastal Jiangsu province near the epicenter of Nanjiang, AP reported.

The CCP has decided to expand travel restrictions on Wednesday: ride-hailing services and public transit have been suspended in all medium- to high-risk areas. Immigration authorities have promised to "strictly restrict non-urgent, unnecessary cross-boarder travel" including restricting the issuing of passports for Chinese citizens. To try and stifle the virus before it has an opportunity to take hold, the city ordered millions of residents to undergo mandatory testing, leading to lines forming across the city. The city has also closed 17 bus lines and a handful of subway stations. Cases have been confirmed in 17 provinces and some two dozen cities, including Wuhan, which reported a handful of cases this week, per CNN.

Fears of another crushing lockdown - many Wuhan residents still have PTSD from the 70-day+ lockdown in the city that was used to crush the original outbreak, at a tremendous cost to the city's residents mental and physical health. Videos and photos shared on social media have shown empty shelves and long lines at supermarkets, as residents scramble to stock up on supplies.

"Seeing Wuhan people panic buying at supermarkets makes me feel sad. Only those who have experienced it understand how terrible it is, (we) dread a return to the days of staying at home and not knowing where the next meal is," said one Wuhan resident on Weibo.

The present outbreak began a little over a week ago in Nanjing, a city in Jiangsu province in eastern China, where nine airport cleaners were found to be infected on July 20 during a routine test. Chinese authorities have blamed the cluster on workers from Russia, who arrived at the Nanjing Lukou International Airport on July 10.

"It is believed that the cleaners did not strictly follow anti-epidemic guidelines after cleaning Flight CA910 and contracted the virus as a result. The infection further spread to other colleagues, who are also responsible for cleaning and transporting garbage on both international and domestic flights," reported state news agency Xinhua.

Given the provenance of the latest outbreak, Beijing has committed to ramp up testing of transport workers around the country. Workers at ports and borders considered high risk will be tested for the virus every other day said Li Huaqiang, a senior official with Ministry of Transport.

Earlier this week, another COVID-19 hotspot was identified in the city of Zhangjiajie, near a scenic area famous for sandstone cliffs, caves, forests and waterfalls.

Despite only confirming some 19 cases over the past week, the city ordered residential communities sealed Sunday, preventing people from leaving their homes. In a subsequent order on Tuesday, officials said no residents, and no tourists, would be allowed to leave the city. On Wednesday, the city government's Communist Party disciplinary committee issued a list of local officials who "had a negative impact" on pandemic prevention and control work who would be punished.

Far higher numbers were reported in Yangzhou, a city next to Nanjing, which has recorded 126 cases as of Tuesday. As a result, all cross-city ferry services, water tours were suspended in eastern Yangzhou on Wednesday.

But most alarmingly, the outbreak has already touched Beijing, eve though it's thousands of miles removed from the epicenter in Nanjiang. On Wednesday, 7 cases were confirmed in the capital city, prompting authorities to lock down two residential compounds.

As of this wee, China has doled out more than 1.71 billion vaccine doses to its population of 1.4 billion. Officials say 40% of the population is fully vaccinated, but the outbreak is also raising questions about the efficacy of those vaccines.

Tyler Durden Wed, 08/04/2021 - 18:00

Read More

Continue Reading

Government

Broward County Public Schools “Pause” Proposed Mask Mandate After DeSantis Threatens To Cut Funding

Broward County Public Schools "Pause" Proposed Mask Mandate After DeSantis Threatens To Cut Funding

Update: Broward County schools on Aug. 3 again changed course on whether to comply with or defy an executive order by Republican Gov. Ron…

Published

on

Broward County Public Schools "Pause" Proposed Mask Mandate After DeSantis Threatens To Cut Funding

Update: Broward County schools on Aug. 3 again changed course on whether to comply with or defy an executive order by Republican Gov. Ron DeSantis which prohibited schools from imposing mask mandates on students.

In a written statement to The Epoch Times, the school board has not changed its policy but “paused it.”

“In light of the governor’s executive order, the district is awaiting further guidance before rendering a decision on the mask mandate for the upcoming school year. At this time, the district’s face covering policy, which requires the use of masks in district schools and facilities, remains in place.”

The School Board plans to discuss next steps at a special meeting on August 10.

Dr. Vickie Cartwright, interim superintendent of Broward County schools is looking into the executive order further.

“The school board is reviewing information and looking for language from our executive rules as a result of the governor’s executive order,” Cartwright said in a video statement.

On July 30, the governor signed an executive order that protects parents’ right to make decisions regarding the masking of their children as a means of protecting them from COVID-19. A month earlier, he signed a bill that protected the parents’ “fundamental right” to make decisions for the upbringing, education, health care, or mental health of their minor children.

“Many Florida schoolchildren have suffered under forced masking policies, and it is prudent to protect the ability of parents to make decisions regarding the wearing of masks by their children,” DeSantis said.

*  *  *

As we detailed earlier, Florida Governor Ron DeSantis has had enough of the Covid hysteria.

Aside from going on record and calling the lockdowns a "huge mistake" back in April of his year, DeSantis has done everything he can to try and turn over the power in his state to its citizens, and away from the government.

The latest example of this comes this week, where DeSantis stood down Florida's second largest school district that was attempting to impose a mask mandate. In response, DeSantis threatened to withhold funding from the district. 

"Broward County Public Schools announced last week that it would require mask use after the CDC issued new guidance recommending universal indoor masking for all teachers, staff, students and visitors to K-12 schools this incoming school year, regardless of vaccination status," Axios reported this week.

DeSantis had issued an executive order last Friday barring schools from requiring masks when school re-opens next month. His order read that "if the State Board of Education determines that a district school board is unwilling or unable to comply with the law, the State Board shall have the authority to, among other things, withhold the transfer of state funds, discretionary grant funds ... and declare the school district ineligible for competitive grants."

And that's exactly what DeSantis threatened to do before Broward County Public Schools backed down, releasing a statement on Monday that said: "Broward County Public Schools intends to comply with the governor's latest executive order."

The statement continued: "Safety remains our highest priority. The district will advocate for all eligible students and staff to receive vaccines and strongly encourage masks to be worn by everyone in schools."

DeSantis also spoke at a press conference this week, stating: “Even among a lot of positive tests, you are seeing much less mortality that you did year-over-year. Would I rather have 5,000 cases among 20-year-olds or 500 cases among seniors? I would rather have the younger.”

“We are not shutting down. We are going to have schools open. We are protecting every Floridian’s job in this state. We are protecting people’s small businesses. These interventions have failed time and time again throughout this pandemic, not just in the United States but abroad.”

As we noted back in April, DeSantis told The Epoch Times that the lockdowns were a “huge mistake,” including in his own state.

“We wanted to mitigate the damage. Now, in hindsight, the 15 days to slow the spread and the 30—it didn’t work,” DeSantis said.

“We shouldn’t have gone down that road.”

Florida’s lockdown order was notably less strict than some of the stay-at-home measures imposed in other states. Recreational activities like walking, biking, golf, and beachgoing were exempted while essential businesses were broadly defined.

“Our economy kept going,” DeSantis said. “It was much different than what you saw in some of those lockdown states.”

DeSantis has also opposed vaccine passports in Florida. 

Tyler Durden Wed, 08/04/2021 - 22:40

Read More

Continue Reading

Spread & Containment

‘For $1/Day’… Double-Blind Ivermectin Study Reveals COVID Patients Recover More Quickly, Are Less Infectious

‘For $1/Day’… Double-Blind Ivermectin Study Reveals COVID Patients Recover More Quickly, Are Less Infectious

A double-blind Israeli study has concluded that Ivermectin, an inexpensive anti-parasitic widely used since 1981, reduces both…

Published

on

'For $1/Day'... Double-Blind Ivermectin Study Reveals COVID Patients Recover More Quickly, Are Less Infectious

A double-blind Israeli study has concluded that Ivermectin, an inexpensive anti-parasitic widely used since 1981, reduces both the duration and infectiousness of Covid-19, according to the Jerusalem Post.

The study, conducted by Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba Medical Center in Tel Hashomer, looked at some 89 eligible volunteers over the age of 18 who had tested positive for coronavirus, and were living in state-run Covid-19 hotels. After being divided into two groups, 50% received ivermectin, and 50% received a placebo. Each patient was given the drug for three days in a row, an hour before eating.

83% of participants were symptomatic at recruitment. 13.5% of patients had comorbidities of cardiovascular disease, diabetes, chronic respiratory disease, hypertension or cancer. The median age of the patients was 35, ranging from 20 to 71-years-old.

Results

Treatment was discontinued on the third day, and patients were monitored every two days thereafter. By day six, 72% of those treated with ivermectin tested negative for the virus, vs. 50% of those who received the placebo. Meanwhile, just 13% of ivermectin patients were able to infect others after six days compared to 50% of the placebo group - nearly four times as many.

Hospitalizations

Three patients in the placebo group were admitted to hospitals for respiratory symptoms, while one ivermectin patient was hospitalized for shortness of breath the day the study began - only to be discharged a day later and "sent back to the hotel in good condition," according to the study.

"Our study shows first and foremost that ivermectin has antiviral activity," said Schwartz, adding "It also shows that there is almost a 100% chance that a person will be noninfectious in four to six days, which could lead to shortening isolation time for these people. This could have a huge economic and social impact."

The study, which appeared on the MedRxiv preprint server and has not yet been peer-reviewed. That said, Schwartz pointed out that similar studies - 'though not all of them conducted to the same double-blind and placebo standards as his' - also showed favorable results for the drug.

Ivermectin is incredibly cheap due to its widespread use across the world to treat malaria, scabies, lice and other parasitic infections. In Bangladesh, the cost of ivermectin is around $0.60 to $1.80 for a five-day course, according to the report. In Israel, it costs up to $10 per day.

While Schwartz's study showed efficacy among those who had already tested positive, it didn't determine whether ivermectin is an effective prophylactic which could prevent one from contracting Covid-19, nor does it show whether it reduces chances of hospitalization - however Schwartz noted that other studies have shown such evidence.

For example, the study published earlier this year in the American Journal of Therapeutics highlighted that “a review by the Front Line COVID-19 Critical Care Alliance summarized findings from 27 studies on the effects of ivermectin for the prevention and treatment of COVID-19 infection, concluding that ivermectin ‘demonstrates a strong signal of therapeutic efficacy’ against COVID-19.”

“Another recent review found that ivermectin reduced deaths by 75%,” the report said. -Jerusalem Post

As the Post notes, Ivermectin has been actively opposed as a Covid treatment by the World Health Organization, the FDA, and pharmaceutical companies.

The “FDA has not approved ivermectin for use in treating or preventing COVID-19 in humans,” it said.

“Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an antiviral (a drug for treating viruses). Taking large doses of this drug is dangerous and can cause serious harm.”

Mere discussion of the drug has resulted in big-tech censoring or deplatforming thought leaders in collaboration with the Biden administration.

Meanwhile, Merck Co. - which manufactured the drug in the 1980s, has come out big against the use of ivermectin to treat Covid-19. In February, the company's website read: "Company scientists continue to carefully examine the findings of all available and emerging studies of Ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to date, our analysis has identified no scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies; no meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and a concerning lack of safety data in the majority of studies."

As the Post points out - Merck has not launched a single study of its own on ivermectin.

"You would think Merck would be happy to hear that ivermectin might be helpful to corona patients and try to study it, but they are most loudly declaring the drug should not be used," said Schwartz.

"A billion people took it. They gave it to them. It’s a real shame."

In closing, the research team writes that "Developing new medications can take years; therefore, identifying existing drugs that can be re-purposed against COVID-19 [and] that already have an established safety profile through decades of use could play a critical role in suppressing or even ending the SARS-CoV-2 pandemic."

"Using re-purposed medications may be especially important because it could take months, possibly years, for much of the world’s population to get vaccinated, particularly among low- to middle-income populations."

Tyler Durden Wed, 08/04/2021 - 18:55

Read More

Continue Reading

Trending